# A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults

> **NCT00437229** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 37 (actual)

## Conditions studied

- Nausea and Vomiting, Chemotherapy-Induced

## Interventions

- **DRUG:** Casopitant (GW679769) Oral Tablets
- **DRUG:** dexamethasone
- **DRUG:** ondansetron

## Key facts

- **NCT ID:** NCT00437229
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-19
- **Primary completion:** 2007-05-15
- **Final completion:** 2007-05-15
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437229, "A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00437229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*